Lyell Immunopharma, Inc. (LYEL): Total Assets
$340.05M
As of 2025-12-31
$311.15M
As of 2026-06-30
-28.7%
3-year compound annual growth
-17.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $340.05M | -30.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $490.86M | -34.6% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $750.03M | -20.0% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $937.56M | -16.8% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $1.13B | +24.1% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $908.28M | n/a | 2022-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
Compare LYEL, NTHI, IBO, ALT side by side · Screen every company in Pharmaceutical Preparations ↗